Radiotherapy for papillary tumor of the pineal region: A systematic review of the literature

Andrea Lancia, Carlotta Becherini, Beatrice Detti, Marta Bottero, Muhammed Baki, Alessandro Cancelli, Amedeo Ferlosio, Silvia Scoccianti, Roger Sun, Lorenzo Livi, Gianluca Ingrosso

Research output: Contribution to journalReview article

Abstract

Papillary tumor of the pineal region (PTPR) is a rare neuroepithelial brain tumor, characterized by a high risk of local recurrence (greater than 70 % at 6 years). The aim of our study was to review the available literature on radiotherapy for PTPR in order to evaluate timings, schedules, outcomes and toxicities of this treatment modality. In our review, 72.4 % (84) of the patients diagnosed with PTPR received radiation therapy. There is heterogeneity in the dose prescription, ranging from 45 Gy (25 × 1.8 Gy) to 60 Gy (30 × 2 Gy) for 3D Conformal Radiation Therapy and from 12 Gy to 36 Gy for Stereotactic Radiosurgery. Being considered as a grade II or III tumor, PTPR should receive higher total radiation dose in the adjuvant setting. Our analysis showed a very limited treatment-related toxicity with an expected 10-y OS of 72.5 %. At 5-years from the diagnosis, about 60 % of the patients experienced a local recurrence, whereas at 10 years the rate is higher than 80 %. In the literature, conflicting data about radiotherapy for PTPR are reported, in particular regarding disease progression. Although radiotherapy represents a fundamental treatment in the management of PTPR, prospective studies are required to better define its impact on overall survival and progression-free survival.

Original languageEnglish
Article number105646
JournalClinical Neurology and Neurosurgery
Volume190
DOIs
Publication statusPublished - Mar 2020
Externally publishedYes

Fingerprint

Pinealoma
Radiotherapy
Neuroepithelial Neoplasms
Recurrence
Radiosurgery
Brain Neoplasms
Disease-Free Survival
Prescriptions
Disease Progression
Appointments and Schedules
Prospective Studies
Radiation
Survival
Therapeutics

Keywords

  • Papillary tumor
  • Pineal region
  • PTPR
  • Radiosurgery
  • Radiotherapy

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Lancia, A., Becherini, C., Detti, B., Bottero, M., Baki, M., Cancelli, A., ... Ingrosso, G. (2020). Radiotherapy for papillary tumor of the pineal region: A systematic review of the literature. Clinical Neurology and Neurosurgery, 190, [105646]. https://doi.org/10.1016/j.clineuro.2019.105646

Radiotherapy for papillary tumor of the pineal region : A systematic review of the literature. / Lancia, Andrea; Becherini, Carlotta; Detti, Beatrice; Bottero, Marta; Baki, Muhammed; Cancelli, Alessandro; Ferlosio, Amedeo; Scoccianti, Silvia; Sun, Roger; Livi, Lorenzo; Ingrosso, Gianluca.

In: Clinical Neurology and Neurosurgery, Vol. 190, 105646, 03.2020.

Research output: Contribution to journalReview article

Lancia, A, Becherini, C, Detti, B, Bottero, M, Baki, M, Cancelli, A, Ferlosio, A, Scoccianti, S, Sun, R, Livi, L & Ingrosso, G 2020, 'Radiotherapy for papillary tumor of the pineal region: A systematic review of the literature', Clinical Neurology and Neurosurgery, vol. 190, 105646. https://doi.org/10.1016/j.clineuro.2019.105646
Lancia, Andrea ; Becherini, Carlotta ; Detti, Beatrice ; Bottero, Marta ; Baki, Muhammed ; Cancelli, Alessandro ; Ferlosio, Amedeo ; Scoccianti, Silvia ; Sun, Roger ; Livi, Lorenzo ; Ingrosso, Gianluca. / Radiotherapy for papillary tumor of the pineal region : A systematic review of the literature. In: Clinical Neurology and Neurosurgery. 2020 ; Vol. 190.
@article{8dcb0b7628404ca6a6b5b7d5a149a2d9,
title = "Radiotherapy for papillary tumor of the pineal region: A systematic review of the literature",
abstract = "Papillary tumor of the pineal region (PTPR) is a rare neuroepithelial brain tumor, characterized by a high risk of local recurrence (greater than 70 {\%} at 6 years). The aim of our study was to review the available literature on radiotherapy for PTPR in order to evaluate timings, schedules, outcomes and toxicities of this treatment modality. In our review, 72.4 {\%} (84) of the patients diagnosed with PTPR received radiation therapy. There is heterogeneity in the dose prescription, ranging from 45 Gy (25 × 1.8 Gy) to 60 Gy (30 × 2 Gy) for 3D Conformal Radiation Therapy and from 12 Gy to 36 Gy for Stereotactic Radiosurgery. Being considered as a grade II or III tumor, PTPR should receive higher total radiation dose in the adjuvant setting. Our analysis showed a very limited treatment-related toxicity with an expected 10-y OS of 72.5 {\%}. At 5-years from the diagnosis, about 60 {\%} of the patients experienced a local recurrence, whereas at 10 years the rate is higher than 80 {\%}. In the literature, conflicting data about radiotherapy for PTPR are reported, in particular regarding disease progression. Although radiotherapy represents a fundamental treatment in the management of PTPR, prospective studies are required to better define its impact on overall survival and progression-free survival.",
keywords = "Papillary tumor, Pineal region, PTPR, Radiosurgery, Radiotherapy",
author = "Andrea Lancia and Carlotta Becherini and Beatrice Detti and Marta Bottero and Muhammed Baki and Alessandro Cancelli and Amedeo Ferlosio and Silvia Scoccianti and Roger Sun and Lorenzo Livi and Gianluca Ingrosso",
year = "2020",
month = "3",
doi = "10.1016/j.clineuro.2019.105646",
language = "English",
volume = "190",
journal = "Clinical Neurology and Neurosurgery",
issn = "0303-8467",
publisher = "Elsevier",

}

TY - JOUR

T1 - Radiotherapy for papillary tumor of the pineal region

T2 - A systematic review of the literature

AU - Lancia, Andrea

AU - Becherini, Carlotta

AU - Detti, Beatrice

AU - Bottero, Marta

AU - Baki, Muhammed

AU - Cancelli, Alessandro

AU - Ferlosio, Amedeo

AU - Scoccianti, Silvia

AU - Sun, Roger

AU - Livi, Lorenzo

AU - Ingrosso, Gianluca

PY - 2020/3

Y1 - 2020/3

N2 - Papillary tumor of the pineal region (PTPR) is a rare neuroepithelial brain tumor, characterized by a high risk of local recurrence (greater than 70 % at 6 years). The aim of our study was to review the available literature on radiotherapy for PTPR in order to evaluate timings, schedules, outcomes and toxicities of this treatment modality. In our review, 72.4 % (84) of the patients diagnosed with PTPR received radiation therapy. There is heterogeneity in the dose prescription, ranging from 45 Gy (25 × 1.8 Gy) to 60 Gy (30 × 2 Gy) for 3D Conformal Radiation Therapy and from 12 Gy to 36 Gy for Stereotactic Radiosurgery. Being considered as a grade II or III tumor, PTPR should receive higher total radiation dose in the adjuvant setting. Our analysis showed a very limited treatment-related toxicity with an expected 10-y OS of 72.5 %. At 5-years from the diagnosis, about 60 % of the patients experienced a local recurrence, whereas at 10 years the rate is higher than 80 %. In the literature, conflicting data about radiotherapy for PTPR are reported, in particular regarding disease progression. Although radiotherapy represents a fundamental treatment in the management of PTPR, prospective studies are required to better define its impact on overall survival and progression-free survival.

AB - Papillary tumor of the pineal region (PTPR) is a rare neuroepithelial brain tumor, characterized by a high risk of local recurrence (greater than 70 % at 6 years). The aim of our study was to review the available literature on radiotherapy for PTPR in order to evaluate timings, schedules, outcomes and toxicities of this treatment modality. In our review, 72.4 % (84) of the patients diagnosed with PTPR received radiation therapy. There is heterogeneity in the dose prescription, ranging from 45 Gy (25 × 1.8 Gy) to 60 Gy (30 × 2 Gy) for 3D Conformal Radiation Therapy and from 12 Gy to 36 Gy for Stereotactic Radiosurgery. Being considered as a grade II or III tumor, PTPR should receive higher total radiation dose in the adjuvant setting. Our analysis showed a very limited treatment-related toxicity with an expected 10-y OS of 72.5 %. At 5-years from the diagnosis, about 60 % of the patients experienced a local recurrence, whereas at 10 years the rate is higher than 80 %. In the literature, conflicting data about radiotherapy for PTPR are reported, in particular regarding disease progression. Although radiotherapy represents a fundamental treatment in the management of PTPR, prospective studies are required to better define its impact on overall survival and progression-free survival.

KW - Papillary tumor

KW - Pineal region

KW - PTPR

KW - Radiosurgery

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=85077053102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077053102&partnerID=8YFLogxK

U2 - 10.1016/j.clineuro.2019.105646

DO - 10.1016/j.clineuro.2019.105646

M3 - Review article

AN - SCOPUS:85077053102

VL - 190

JO - Clinical Neurology and Neurosurgery

JF - Clinical Neurology and Neurosurgery

SN - 0303-8467

M1 - 105646

ER -